Solventum Corporation reaffirmed earnings guidance for its full-year 2024. For the period, Company expects Organic revenue growth of -2% to 0%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.6 USD | +0.29% |
|
+0.68% | 0.00% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 8.91B | |
+18.11% | 83.73B | |
-27.15% | 72.21B | |
-0.56% | 26.2B | |
-10.81% | 17.09B | |
+2.00% | 17.18B | |
-0.90% | 15.18B | |
+76.72% | 13.59B | |
+77.64% | 13.11B | |
-23.51% | 12.92B |
- Stock Market
- Equities
- SOLV Stock
- News Solventum Corporation
- Solventum Corporation Reaffirms Earnings Guidance for Its Full-Year 2024